LOGIN
Efficacy & Safety of Flurbiprofen Cataplasms vs. Loxoprofen Sodium Cataplasms in Knee Osteoarthritis
February 2025
Efficacy & Safety of Flurbiprofen Cataplasms vs. Loxoprofen Sodium Cataplasms in Knee Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial.
Chin Med J (Engl) . 2023 Sep 20;136(18):2187-2194.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Two hundred fifty patients with knee osteoarthritis were randomized to receive either flurbiprofen cataplasms (FPC) (n=124) or loxoprofen sodium cataplasms (LSC) (n=125) for 28 days. The primary outcome of interest was the change in pain intensity measured by the visual analog scale (VAS) from baseline to day 28. Secondary outcomes included the extent of pain relief, changes in joint function asse...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.